DK0749498T3 - Genetiske markører, der i forening anvendes til diagnose af Alzheimer's sygdom, metode og diagnosekit - Google Patents

Genetiske markører, der i forening anvendes til diagnose af Alzheimer's sygdom, metode og diagnosekit

Info

Publication number
DK0749498T3
DK0749498T3 DK95911377T DK95911377T DK0749498T3 DK 0749498 T3 DK0749498 T3 DK 0749498T3 DK 95911377 T DK95911377 T DK 95911377T DK 95911377 T DK95911377 T DK 95911377T DK 0749498 T3 DK0749498 T3 DK 0749498T3
Authority
DK
Denmark
Prior art keywords
alzheimer
diagnosis
disease
pct
genetic markers
Prior art date
Application number
DK95911377T
Other languages
Danish (da)
English (en)
Inventor
Philippe Amouyel
Marie-Christin Chartier-Harlin
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0749498T3 publication Critical patent/DK0749498T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK95911377T 1994-03-07 1995-03-06 Genetiske markører, der i forening anvendes til diagnose af Alzheimer's sygdom, metode og diagnosekit DK0749498T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402603A FR2716894B1 (fr) 1994-03-07 1994-03-07 Marqueurs génétiques utilisés conjointement pour le diagnostic de la maladie d'Alzheimer, méthode et kit de diagnostic.
PCT/FR1995/000259 WO1995024504A1 (fr) 1994-03-07 1995-03-06 Marqueurs genetiques utilises conjointement pour le diagnostic de la maladie d'alzheimer, methode et kit de diagnostic

Publications (1)

Publication Number Publication Date
DK0749498T3 true DK0749498T3 (da) 1999-05-10

Family

ID=9460754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95911377T DK0749498T3 (da) 1994-03-07 1995-03-06 Genetiske markører, der i forening anvendes til diagnose af Alzheimer's sygdom, metode og diagnosekit

Country Status (9)

Country Link
US (1) US5942392A (de)
EP (1) EP0749498B1 (de)
JP (1) JP3662585B2 (de)
AT (1) ATE169343T1 (de)
CA (1) CA2184635C (de)
DE (1) DE69503885T2 (de)
DK (1) DK0749498T3 (de)
FR (1) FR2716894B1 (de)
WO (1) WO1995024504A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
ES2128265B1 (es) * 1997-06-04 2000-03-01 Euroespes S A Kit genetico para la caracterizacion molecular de la enfermedad de alzheimer.
FR2765591B1 (fr) * 1997-07-01 2002-08-09 Pasteur Institut Procede de diagnostic de la maladie d'alzheimer
AU734779B2 (en) * 1997-09-12 2001-06-21 Bristol-Myers Squibb Company Method for determining propensity for developing late-onset Alzheimer's disease
US6251587B1 (en) 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
US6703228B1 (en) 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
EP1001037A3 (de) * 1998-09-28 2003-10-01 Whitehead Institute For Biomedical Research Vorselektion und Isolierung eines Einzelnukleotidpolymorphismus
DE69903278D1 (de) * 1999-07-09 2002-11-07 Inst Pasteur De Lille Lille Verfahren zur Diagnose oder zur Prognose von Alzheimer Krankheit: therapeutische Zusammensetzung zur Verhinderung oder zur Behandlung von Alzheimer Krankheit
WO2004011943A1 (en) * 2002-07-30 2004-02-05 The Regents Of The University Of California Method of diagnosing alzheimer's disease
EP1623996A1 (de) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Verbessertes Verfahren zur Auswahl eines Proteins von einer Bibliothek
US8071307B2 (en) 2005-04-04 2011-12-06 Asubio Pharma Co., Ltd. Method of detecting relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis
US9335331B2 (en) * 2005-04-11 2016-05-10 Cornell Research Foundation, Inc. Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject
ES2404311T3 (es) 2005-04-12 2013-05-27 454 Life Sciences Corporation Métodos para determinar variantes de secuencias usando secuenciación ultraprofunda
US20060228721A1 (en) 2005-04-12 2006-10-12 Leamon John H Methods for determining sequence variants using ultra-deep sequencing
JP2010521156A (ja) * 2007-03-16 2010-06-24 ４５４ ライフ サイエンシーズ コーポレイション Ｈｉｖ薬物耐性バリアントの検出のためのシステムおよび方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3265577B2 (ja) * 1992-10-13 2002-03-11 デューク・ユニバーシティ アポリポ蛋白ｅの４型イソ型の測定法

Also Published As

Publication number Publication date
DE69503885D1 (de) 1998-09-10
JP3662585B2 (ja) 2005-06-22
EP0749498A1 (de) 1996-12-27
ATE169343T1 (de) 1998-08-15
EP0749498B1 (de) 1998-08-05
JPH09511138A (ja) 1997-11-11
DE69503885T2 (de) 1999-04-22
FR2716894A1 (fr) 1995-09-08
CA2184635A1 (fr) 1995-09-14
FR2716894B1 (fr) 1996-05-24
WO1995024504A1 (fr) 1995-09-14
CA2184635C (fr) 2008-11-18
US5942392A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
DK0749498T3 (da) Genetiske markører, der i forening anvendes til diagnose af Alzheimer's sygdom, metode og diagnosekit
GB2348425B (en) Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to binds to preselected sites
CA2316808A1 (en) Transgenic rabbit that expresses a functional human lipoprotein (a)
DE69435162D1 (de) Chemisch modifizierter Gewebeinhibitor für Metalloproteasen Type 3 (TIMP-3)
IS5638A (is) Smílagenín og anzúrógenín-D til meðhöndlunar á Alzheimers-sjúkdómi
PT1645631E (pt) Anitigénios da neisseria meningitidis e composições
DK0763055T3 (da) Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
ATE202487T1 (de) Mono- oder polyfunktionelle konjugate von polylysine
EP1748078A3 (de) Kombinationsoligomere betreffende Verfahren, Kits und Zusammensetzungen
EP0731636A4 (de) Apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
DE68904617D1 (de) Jodhaltige polymere mit skeletten von dextran, verfahren zu ihrer herstellung und ihre verwendungen als kontrastmittel.
AU2174392A (en) Adn sequences of the human papillomavirus type 42, and diagnostic application thereof
WO2002062197A3 (en) Markers for disease susceptibility and targets for therapy
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
EP1019092A4 (de) Therapeutische und diagnostische mittel für krankheiten mit gestörter glukose-toleranz
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
DE602004030107D1 (de) Suszeptibilitätsgen für die alzheimersche krankheit
DE69834422D1 (de) Klonierungsverfahren durch multiple verdauung
ATE319826T1 (de) Minimale promotoren und ihre verwendung